Skip to content

Depression: all studies

Page 396 of 1,034: studies 3,951 to 3,960 of 10,336, newest first. Back to the depression overview

Research

The Implementation of Mindfulness-Based Programs in the Swedish Healthcare System - A Survey Study of Service Providers.

Global Advances in Health and Medicine 2021 Maria Niemi, Rebecca S. Crane, Jermo Sinselmeijer et al.

The burden of depression and anxiety is on the rise globally. Mindfulness-Based Programs (MBPs) are a particular group of psychosocial programs targeting depression and anxiety. There is growing research and practice interest in MBPs internationally, and they are becoming more commonly implemented in a number of countries' healthcare services. To systematically map the existing provision of...

Mindfulness-based intervention for college faculties and students in Brazil.

Education for health 2021 Sara de Pinho Cunha Paiva, Fernanda Freire Campos Nunes, Braulio Roberto Gonçalves Marinho Couto et al.

Teacher and students' stress has been a challenge in education. An approach to stress reduction is mindfulness training. The Mindfulness-based stress reduction (MBSR) has been used to improve the condition of individuals with various health outcomes. The aim of this study was to examine whether MBSR may improve depression, well-being, and perceived stress of Brazilian college faculty and...

Peripheral biomarkers in Repeated Ketamine Infusions Trial

2021 Amanda van Geel

Abnormalities in the endocrine and immune systems are well documented in patients with Major Depressive Disorder (MDD), however, the mechanisms by which the novel antidepressant treatment, ketamine, influences these physiological systems are unclear. This study examined the effects of repeated ketamine infusions on the endocrine and immune systems using the peripheral biomarkers C-reactive...

Psychosis induced by abuse of ayahuasca: a case report.

Revista Colombiana de psiquiatria 2021 Raul Felipe Palma-álvarez, Lara Grau-López, Elena Ros-Cucurull et al. 12 citations

Ayahuasca is a psychotropic infusion prepared by boiling the bark of Amazonian plants and has many psychopharmacological effects not fully understood. Some of those effects are used as treatment for different diseases. However, the side effects of ayahuasca, including ayahuasca-induced psychosis, are an important issue. Here we report the case of a patient who had a psychotic episode after...

What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review

Porto Biomedical Journal 2021 Henrique Castro Santos, João Gama Marques 37 citations

Abstract Background: Psilocybin is a predominant agonist of 5HT 1A and 5HT 2A/C receptors and was first isolated in 1958, shortly before it became a controlled substance. Research on the potential therapeutic effects of this compound has recently re-emerged alongside what is being addressed as a psychedelic renaissance. Methods: In this paper we performed a systematic review of the clinical...

Brief EcoMeditation Associated With Psychological Improvements: A Preliminary Study.

Global Advances in Health and Medicine December 23, 2020 Dawson Church, Peta Stapleton, Debbie Sabot

Background: A growing body of clinical research attests to the psychological and physiological benefits of meditation. EcoMeditation is a non-pharmacological therapeutic approach used to promote health and well-being, comprising four evidence-based techniques: The Quick Coherence Technique for regulating heart rate variability (HRV), Emotional Freedom Techniques (EFT), mindfulness, and...

Mindfulness and Shinrin-Yoku: Potential for Physiological and Psychological Interventions during Uncertain Times.

International Journal of Environmental Research and Public Health December 14, 2020 Erica R Timko Olson, Margaret M Hansen, Amber L Vermeesch

Mindfulness and Shinrin-yoku (SY) translated as forest bathing, is potentially effective to alleviate mental health issues related to the COVID-19 pandemic and beyond. The purpose of this article is to provide a translational and pragmatic approach to understanding mindfulness in the context of SY and psychological wellbeing through a rapid review of the literature. The background of...

Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation

CNS Spectrums December 10, 2020 Nelson B Rodrigues, Ashley N. Siegel, Orly Lipsitz et al. 17 citations

BACKGROUND: Patients unsuccessfully treated by neurostimulation may represent a highly intractable subgroup of depression. While the efficacy of intravenous (IV) ketamine has been established in patients with treatment-resistant depression (TRD), there is an interest to evaluate its effectiveness in a subpopulation with a history of neurostimulation. METHODS: This retrospective, posthoc...

Mindfulness and psychological health in practitioners of Japanese martial arts: a cross-sectional study.

BMC sports science, medicine & rehabilitation December 7, 2020 Hiromitsu Miyata, Daisuke Kobayashi, Akifumi Sonoda et al.

Background: Empirical data have suggested that mind-body practices that originated in Eastern traditions can cause desirable changes to psychological traits, the brain, somatic physiological functions, etc. Martial arts in Japan refer to the physical/mental practices that were developed based on historical combat techniques. Today, martial arts are considered activities that seek embodiment...

Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence

CNS Spectrums December 3, 2020 Orly Lipsitz, Roger S McIntyre, Nelson B Rodrigues et al. 25 citations

BACKGROUND: Higher body mass index (BMI) has been found to predict greater antidepressant response to intravenous (IV) ketamine treatment. We evaluated the association between BMI and response to repeat-dose IV ketamine in patients with treatment-resistant depression (TRD). METHODS: Adults (N = 230) with TRD received four infusions of IV ketamine at a community-based clinic. Changes in symptoms...